Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service CGM & insulin pump management cases in North Carolina: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 3% on average (248 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 127 | 12,500 | 40% |
| 2020 | 153 | 14,424 | 43% |
| 2021 | 188 | 19,918 | 48% |
| 2022 | 205 | 22,756 | 52% |
| 2023 | 214 | 25,067 | 56% |
| 2024 | 229 | 28,955 | 59% |
| 2025 from claims | – | 32,170 29,523–34,036 | 61% |
| 2026 forecast | – | 35,078 30,863–40,478 | 62% |
| 2027 forecast | – | 38,090 32,563–45,392 | 62% |
| 2028 forecast | – | 41,337 34,492–50,616 | 63% |
| 2029 forecast | – | 44,834 36,618–56,225 | 64% |
| 2030 forecast | – | 48,595 38,931–62,274 | 65% |
CGM setup and interpretation codes identify who prescribes diabetes technology. Professional codes (what the surgeon bills): CPT 95249, 95250, 95251.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 16% of the cases CMS names in North Carolina; 118 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 13% hospital outpatient, 87% office. The share outside the hospital has moved −7 pts since 2019.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Florida | 404 | 65,371+15%/yr | +15%/yr | 28.7 | 96% | 130,100 in 2030+12%/yr |
| Texas | 452 | 65,364+17%/yr | +17%/yr | 29.8 | 92% | 129,200 in 2030+12%/yr |
| Georgia | 210 | 27,583+22%/yr | +22%/yr | 31.3 | 99% | 50,800 in 2030+11%/yr |
| Maryland | 171 | 26,549+30%/yr | +30%/yr | 29.8 | 87% | 49,300 in 2030+11%/yr |
| Virginia | 186 | 25,175+32%/yr | +32%/yr | 23.7 | 75% | 49,200 in 2030+12%/yr |
| Tennessee | 150 | 20,740+27%/yr | +27%/yr | 29.0 | 93% | 38,400 in 2030+11%/yr |
| South Carolina | 108 | 17,936+27%/yr | +27%/yr | 25.8 | 93% | 35,200 in 2030+12%/yr |
| Kentucky | 110 | 12,522+26%/yr | +26%/yr | 26.8 | 83% | 22,100 in 2030+9.9%/yr |
| Oklahoma | 89 | 11,902+33%/yr | +33%/yr | 24.2 | 84% | 19,400 in 2030+8.5%/yr |
| Alabama | 73 | 11,837+23%/yr | +23%/yr | 26.4 | 81% | 19,400 in 2030+8.6%/yr |
| Mississippi | 54 | 11,559+40%/yr | +40%/yr | 30.4 | 85% | 20,500 in 2030+10%/yr |
| Louisiana | 83 | 11,500+25%/yr | +25%/yr | 27.6 | 78% | 18,600 in 2030+8.3%/yr |
| Arkansas | 47 | 10,160+31%/yr | +31%/yr | 26.5 | 84% | 16,600 in 2030+8.6%/yr |
| Delaware | 25 | 4,890+35%/yr | +35%/yr | 28.2 | 80% | 8,660 in 2030+10%/yr |
| West Virginia | 43 | 4,488+28%/yr | +28%/yr | 21.1 | 34% | 8,070 in 2030+10%/yr |
| District of Columbia | 17 | 1,276+12%/yr | +12%/yr | 20.1 | 100% | 2,370 in 2030+11%/yr |
CGM & insulin pump management in every state, and its device makers · Every procedure market in North Carolina · Every state · Compare with Florida
Abbott leads with 47% of company spending on these surgeons in 2025, −6 pts on 2024.
In 2025, 8 companies reported engagement with North Carolina’s surgeons worth $390K in consulting, speaking, meals and travel tied to these products, about $1,705 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 37 clearances and approvals in the category, 33 recalled product lines (8 Class I). A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.
For CPT 95249 (cont gluc mntr pt prov eqp), commercial plans pay North Carolina’s hospitals a median of $58, from $58 at the lowest to $343 at the highest, across 8 hospitals that publish a price.
Each hospital’s median over its commercial plans, from the machine-readable files hospitals must post; not every hospital is loaded.